Page last updated: 2024-11-07

penicillamine and Atherogenesis

penicillamine has been researched along with Atherogenesis in 2 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kyselovic, J1
Martinka, P1
Batova, Z1
Gazova, A1
Godfraind, T1
Martinet, W1
Croons, V1
Timmermans, JP1
Herman, AG1
De Meyer, GR1

Other Studies

2 other studies available for penicillamine and Atherogenesis

ArticleYear
Calcium channel blocker inhibits Western-type diet-evoked atherosclerosis development in ApoE-deficient mice.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:1

    Topics: Acetylcholine; Animals; Apolipoproteins E; Atherosclerosis; Calcium Channel Blockers; Cholesterol, H

2005
Nitric oxide selectively depletes macrophages in atherosclerotic plaques via induction of endoplasmic reticulum stress.
    British journal of pharmacology, 2007, Volume: 152, Issue:4

    Topics: Animals; Apoptosis; Atherosclerosis; Caspase 3; Cell Line; Cell Survival; Cells, Cultured; Endoplasm

2007